You are here: For the applicantsNews and eventsCalls and funding newsHorizon 2020
Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic
Clinical and public health response to the 2019-nCoV epidemic
04 February 2020
Modified: 08 April 2020
Reading time: 2 minute(s)
The European Commission is boosting urgently needed research into coronavirus with €10 million from its research and innovation programme, Horizon 2020.

Proposals submitted under this expression of interest are expected to advance the knowledge on 2019-nCoV and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response. Proposals must be timely, with rapid activation, to enable early and valuable outcomes to be established. For increased impact, proposals may wish to build on promising avenues from previous or ongoing research.

Considering that this is a newly identified virus, the scope of this expression of interest remains broad and may include topics such as:

  • Development of therapeutics, including monoclonal antibodies. As relevant, evidence of regulatory and ethics approvals for the investigational products included in the study(ies) must be presented.
  • Development of point of care diagnostics, ensuring rapid evaluation of candidates based on existing technologies, to allow for fast case detection and surveillance.
  • Clinical and epidemiological studies, to provide data on epidemiological characteristics such as viral genotype and pathogenicity; clinical information on host susceptibility and host immune responses; risk factors for severe disease; routes of transmission and their relative importance; identification of the animal reservoir; etc.
  • Social sciences research, to provide urgently needed answers to social dynamics of the outbreak and the related public health response.

Budget: 10 000 000 EUR

Deadline: 12 February 2020 17:00:00 Brussels time

More info:

Updated: 08 April 2020
Was this page helpful?